DiscoverThe Metabolomist podcastPersonalized medicine & survival prediction | Robert Nagourney
Personalized medicine & survival prediction | Robert Nagourney

Personalized medicine & survival prediction | Robert Nagourney

Update: 2024-04-09
Share

Description

Robert Nagourney MD, is Medical and Laboratory Director of The Nagourney Cancer Institute in Long Beach, California, Associate Clinical Professor, at University of California Irvine and founder and CEO of Metabolomycs, Inc. He is board certified in internal medicine, medical oncology, and hematology.


Favorite metabolite

Glutamine


Learn more about his work:

Nagourney Cancer Institute

Metabolomycs

TEDx talk


Paper we discussed in this episode

Ovarian cancer | Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis

Pancreatic cancer | Diagnostic and Prognostic Performance of Metabolic Signatures in Pancreatic Ductal Adenocarcinoma: The Clinical Application of Quantitative NextGen Mass Spectrometry


Sign up for The Metabolomist mailing list to be the first to hear about the latest episodes and news around metabolomics at https://themetabolomist.com


Alices first book

The STORY principle - A guide to the biological interpretation of metabolomics

Also featuring some of the Metabolomists from Season 1

Available on Amazon and the biocrates webshop

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Personalized medicine & survival prediction | Robert Nagourney

Personalized medicine & survival prediction | Robert Nagourney

biocrates life sciences